174 related articles for article (PubMed ID: 18716009)
1. Impact of clinical variables on Borrelia burgdorferi-specific antibody seropositivity in acute-phase sera from patients in North America with culture-confirmed early Lyme disease.
Wormser GP; Nowakowski J; Nadelman RB; Visintainer P; Levin A; Aguero-Rosenfeld ME
Clin Vaccine Immunol; 2008 Oct; 15(10):1519-22. PubMed ID: 18716009
[TBL] [Abstract][Full Text] [Related]
2. Prospective study of serologic tests for lyme disease.
Steere AC; McHugh G; Damle N; Sikand VK
Clin Infect Dis; 2008 Jul; 47(2):188-95. PubMed ID: 18532885
[TBL] [Abstract][Full Text] [Related]
3. Serologic evaluation of patients from Missouri with erythema migrans-like skin lesions with the C6 Lyme test.
Philipp MT; Masters E; Wormser GP; Hogrefe W; Martin D
Clin Vaccine Immunol; 2006 Oct; 13(10):1170-1. PubMed ID: 17028220
[TBL] [Abstract][Full Text] [Related]
4. Comparison of different Borrelia burgdorferi sensu lato strains for detection of immune response in patients with erythema migrans.
Merljak Skocir L; Ruzić-Sabljić E; Maraspin-Carman V; Lotric-Furlan S; Logar M; Strle F
Int J Med Microbiol; 2008 Jul; 298(5-6):493-504. PubMed ID: 17892971
[TBL] [Abstract][Full Text] [Related]
5. Use of serum immune complexes in a new test that accurately confirms early Lyme disease and active infection with Borrelia burgdorferi.
Brunner M; Sigal LH
J Clin Microbiol; 2001 Sep; 39(9):3213-21. PubMed ID: 11526153
[TBL] [Abstract][Full Text] [Related]
6. Effect of Borrelia burgdorferi genotype on the sensitivity of C6 and 2-tier testing in North American patients with culture-confirmed Lyme disease.
Wormser GP; Liveris D; Hanincová K; Brisson D; Ludin S; Stracuzzi VJ; Embers ME; Philipp MT; Levin A; Aguero-Rosenfeld M; Schwartz I
Clin Infect Dis; 2008 Oct; 47(7):910-4. PubMed ID: 18724824
[TBL] [Abstract][Full Text] [Related]
7. Comparative reactivity of human sera to recombinant VlsE and other Borrelia burgdorferi antigens in class-specific enzyme-linked immunosorbent assays for Lyme borreliosis.
Magnarelli LA; Lawrenz M; Norris SJ; Fikrig E
J Med Microbiol; 2002 Aug; 51(8):649-655. PubMed ID: 12171295
[TBL] [Abstract][Full Text] [Related]
8. Serodiagnosis of Lyme disease by kinetic enzyme-linked immunosorbent assay using recombinant VlsE1 or peptide antigens of Borrelia burgdorferi compared with 2-tiered testing using whole-cell lysates.
Bacon RM; Biggerstaff BJ; Schriefer ME; Gilmore RD; Philipp MT; Steere AC; Wormser GP; Marques AR; Johnson BJ
J Infect Dis; 2003 Apr; 187(8):1187-99. PubMed ID: 12695997
[TBL] [Abstract][Full Text] [Related]
9. Comparison of whole-cell antibodies and an antigenic flagellar epitope of Borrelia burgdorferi in serologic tests for diagnosis of Lyme borreliosis.
Magnarelli LA; Fikrig E; Berland R; Anderson JF; Flavell RA
J Clin Microbiol; 1992 Dec; 30(12):3158-62. PubMed ID: 1280650
[TBL] [Abstract][Full Text] [Related]
10. Serodiagnosis of erythema migrans and acrodermatitis chronica atrophicans by the Borrelia burgdorferi flagellum enzyme-linked immunosorbent assay.
Hansen K; Asbrink E
J Clin Microbiol; 1989 Mar; 27(3):545-51. PubMed ID: 2715325
[TBL] [Abstract][Full Text] [Related]
11. Antibody responses to borrelia IR(6) peptide variants and the C6 peptide in Swedish patients with erythema migrans.
Tjernberg I; Sillanpää H; Seppälä I; Eliasson I; Forsberg P; Lahdenne P
Int J Med Microbiol; 2009 Aug; 299(6):439-46. PubMed ID: 19138558
[TBL] [Abstract][Full Text] [Related]
12. Immune complexes in early Lyme disease.
Lencáková D; Stefancíková A; Ivanová R; Petko B
Can J Microbiol; 2007 Dec; 53(12):1375-7. PubMed ID: 18059570
[TBL] [Abstract][Full Text] [Related]
13. Seroprevalence of Infection by
Stadelmann K; Forestier E; Richalet G; Monnet V; Epaulard O
Vector Borne Zoonotic Dis; 2024 Apr; 24(4):196-200. PubMed ID: 38441498
[No Abstract] [Full Text] [Related]
14. Enzyme-linked immunosorbent assay, immunofluorescent assay, and recombinant immunoblotting in the serodiagnosis of early Lyme borreliosis.
Christova I
Int J Immunopathol Pharmacol; 2003; 16(3):261-8. PubMed ID: 14611730
[TBL] [Abstract][Full Text] [Related]
15. Borrelia burgdorferi-specific IgA in Lyme Disease.
D'Arco C; Dattwyler RJ; Arnaboldi PM
EBioMedicine; 2017 May; 19():91-97. PubMed ID: 28457619
[TBL] [Abstract][Full Text] [Related]
16. Predictive value of Borrelia burgdorferi IgG antibody levels in patients referred to a tertiary Lyme centre.
Zwerink M; Zomer TP; van Kooten B; Blaauw G; van Bemmel T; van Hees BC; Vermeeren YM; Landman GW
Ticks Tick Borne Dis; 2018 Mar; 9(3):594-597. PubMed ID: 29422448
[TBL] [Abstract][Full Text] [Related]
17. Recombinant OspC from Borrelia burgdorferi sensu stricto, B. afzelii and B. garinii in the serodiagnosis of Lyme borreliosis.
Panelius J; Lahdenne P; Heikkilä T; Peltomaa M; Oksi J; Seppälä I
J Med Microbiol; 2002 Sep; 51(9):731-739. PubMed ID: 12358063
[TBL] [Abstract][Full Text] [Related]
18. Polymerase chain reaction in diagnosis of Borrelia burgdorferi infections and studies on taxonomic classification.
Lebech AM
APMIS Suppl; 2002; (105):1-40. PubMed ID: 11985118
[TBL] [Abstract][Full Text] [Related]
19. Linear B Cell Epitopes Derived from the Multifunctional Surface Lipoprotein BBK32 as Targets for the Serodiagnosis of Lyme Disease.
Toumanios C; Prisco L; Dattwyler RJ; Arnaboldi PM
mSphere; 2019 May; 4(3):. PubMed ID: 31043513
[TBL] [Abstract][Full Text] [Related]
20. Evaluation of Selected Borrelia burgdorferi lp54 Plasmid-Encoded Gene Products Expressed during Mammalian Infection as Antigens To Improve Serodiagnostic Testing for Early Lyme Disease.
Weiner ZP; Crew RM; Brandt KS; Ullmann AJ; Schriefer ME; Molins CR; Gilmore RD
Clin Vaccine Immunol; 2015 Nov; 22(11):1176-86. PubMed ID: 26376927
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
